Published in Antimicrob Agents Chemother on August 12, 2013
The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev (2015) 1.81
Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections. Drugs (2014) 1.06
Contribution of resistance-nodulation-cell division efflux systems to antibiotic resistance and biofilm formation in Acinetobacter baumannii. MBio (2015) 1.04
Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options. Semin Respir Crit Care Med (2015) 0.99
A novel method of consensus pan-chromosome assembly and large-scale comparative analysis reveal the highly flexible pan-genome of Acinetobacter baumannii. Genome Biol (2015) 0.93
Analysis of the role of the LH92_11085 gene of a biofilm hyper-producing Acinetobacter baumannii strain on biofilm formation and attachment to eukaryotic cells. Virulence (2016) 0.84
In vitro and in vivo analysis of antimicrobial agents alone and in combination against multi-drug resistant Acinetobacter baumannii. Front Microbiol (2015) 0.83
An outbreak of blaOXA-51-like- and blaOXA-66-positive Acinetobacter baumannii ST208 in the emergency intensive care unit. J Med Microbiol (2014) 0.82
Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia. Clin Microbiol Rev (2016) 0.81
Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump. Antimicrob Agents Chemother (2015) 0.80
Identification of Acinetobacter baumannii serum-associated antibiotic efflux pump inhibitors. Antimicrob Agents Chemother (2014) 0.79
Prevalence of Genes of OXA-23 Carbapenemase and AdeABC Efflux Pump Associated with Multidrug Resistance of Acinetobacter baumannii Isolates in the ICU of a Comprehensive Hospital of Northwestern China. Int J Environ Res Public Health (2015) 0.78
Contribution of the Ade Resistance-Nodulation-Cell Division-Type Efflux Pumps to Fitness and Pathogenesis of Acinetobacter baumannii. MBio (2016) 0.76
Global regulator SoxR is a negative regulator of efflux pump gene expression and affects antibiotic resistance and fitness in Acinetobacter baumannii. Medicine (Baltimore) (2017) 0.76
In Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2016) 0.75
A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism. Antimicrob Agents Chemother (2016) 0.75
Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme. PLoS One (2017) 0.75
Resistance mechanisms. Ann Transl Med (2016) 0.75
Emergence of Hospital Acquired Carbapenem Resistant Non-Fermenters in Teaching Institute. J Clin Diagn Res (2016) 0.75
AdeRS combination codes differentiate the response to efflux pump inhibitors in tigecycline-resistant isolates of extensively drug-resistant Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis (2014) 0.75
Molecular Characterization of Reduced Susceptibility to Biocides in Clinical Isolates of Acinetobacter baumannii. Front Microbiol (2017) 0.75
Phenotype microarray analysis of the AdeRS two-component system in Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis (2017) 0.75
Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections. Infect Dis Ther (2017) 0.75
Contribution of TetB Efflux Pump on Minocycline Susceptibility among Carbapenem-Resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2017) 0.75
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol (1995) 88.05
Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev (2008) 17.77
Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2007) 7.84
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect (2006) 6.40
Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J Antimicrob Chemother (2006) 4.73
Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol (1995) 4.25
Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol (2006) 3.98
Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol (2005) 3.68
Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother (2001) 3.56
OXA-type carbapenemases. J Antimicrob Chemother (2006) 3.15
Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect (2005) 2.49
Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother (2000) 2.23
OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother (2009) 2.05
AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrob Agents Chemother (2007) 2.04
Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother (2010) 1.89
Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems. FEMS Microbiol Rev (2009) 1.79
Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J Antimicrob Chemother (2008) 1.71
AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii. J Antimicrob Chemother (2010) 1.67
OXA-24 carbapenemase gene flanked by XerC/XerD-like recombination sites in different plasmids from different Acinetobacter species isolated during a nosocomial outbreak. Antimicrob Agents Chemother (2010) 1.67
Diversity of tetracycline resistance genes in bacteria from Chilean salmon farms. Antimicrob Agents Chemother (2003) 1.59
Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii. Antimicrob Agents Chemother (2010) 1.58
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii. Antimicrob Agents Chemother (2007) 1.57
AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters. Antimicrob Agents Chemother (2005) 1.55
Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study. Antimicrob Agents Chemother (2011) 1.54
Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance. J Clin Microbiol (2002) 1.45
Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy. J Antimicrob Chemother (2011) 1.43
High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin Microbiol Infect (2007) 1.40
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray. Antimicrob Agents Chemother (2009) 1.36
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother (2010) 1.33
CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii. Antimicrob Agents Chemother (2009) 1.27
Cloning and functional analysis of the gene encoding the 33- to 36-kilodalton outer membrane protein associated with carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother (2005) 1.25
Aminoglycoside resistance and susceptibility testing errors in Acinetobacter baumannii-calcoaceticus complex. J Clin Microbiol (2010) 1.23
Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide. J Antimicrob Chemother (2006) 1.20
Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS. Clin Microbiol Infect (2011) 1.14
Molecular and functional characterization of a novel efflux pump, AmvA, mediating antimicrobial and disinfectant resistance in Acinetobacter baumannii. J Antimicrob Chemother (2010) 1.10
Rapid determination of quinolone resistance in Acinetobacter spp. J Clin Microbiol (2009) 1.09
In vitro activity of doripenem against Acinetobacter baumannii clinical isolates. Int J Antimicrob Agents (2008) 1.08
Tetracycline susceptibility testing and resistance genes in isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex from a U.S. military hospital. Antimicrob Agents Chemother (2009) 1.06
Expression of the resistance-nodulation-cell division pump AdeIJK in Acinetobacter baumannii is regulated by AdeN, a TetR-type regulator. Antimicrob Agents Chemother (2012) 1.04
Detection of intrinsic blaOXA-51-like by multiplex PCR on its own is not reliable for the identification of Acinetobacter baumannii. Int J Med Microbiol (2013) 1.01
Multidrug resistance pump AcrAB-TolC is required for high-level, Tet(A)-mediated tetracycline resistance in Escherichia coli. J Antimicrob Chemother (2006) 0.99
Identification of Tet 39, a novel class of tetracycline resistance determinant in Acinetobacter spp. of environmental and clinical origin. J Antimicrob Chemother (2005) 0.96
Overexpression of the adeB gene in clinical isolates of tigecycline-nonsusceptible Acinetobacter baumannii without insertion mutations in adeRS. Antimicrob Agents Chemother (2010) 0.93
A truncated AdeS kinase protein generated by ISAba1 insertion correlates with tigecycline resistance in Acinetobacter baumannii. PLoS One (2012) 0.91
[In vitro activity of 18 antimicrobial agents against clinical isolates of Acinetobacter spp.: multicenter national study GEIH-REIPI-Ab 2010]. Enferm Infecc Microbiol Clin (2012) 0.90
Presence of the Tet M determinant in a clinical isolate of Acinetobacter baumannii. Antimicrob Agents Chemother (2003) 0.90
Sequence-based typing of ade B as a potential tool to identify intraspecific groups among clinical strains of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol (2005) 0.89
Diversity of aminoglycoside modifying enzyme genes among multidrug resistant Acinetobacter baumannii genotypes isolated from nosocomial infections in Tehran hospitals and their association with class 1 integrons. Acta Microbiol Immunol Hung (2011) 0.82
Establishment of a novel target-based real-time quantitative PCR method for Acinetobacter baumannii detection. Diagn Mol Pathol (2011) 0.77
Quinolone resistance from a transferable plasmid. Lancet (1998) 11.28
Nuclear hormone receptors and gene expression. Physiol Rev (2001) 4.56
Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob Agents Chemother (1999) 3.85
Complete DNA sequence of yeast chromosome XI. Nature (1994) 3.51
Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology (1999) 3.49
Rapid fluorescence method for screening Salmonella spp. from enteric differential agars. J Clin Microbiol (1990) 2.84
Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol (2001) 2.73
Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus. EMBO J (1987) 2.67
Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. Antimicrob Agents Chemother (1998) 2.60
[Socioeconomic determinants and utilization of emergency hospital services]. Med Clin (Barc) (1997) 2.57
Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase. J Antimicrob Chemother (2003) 2.37
Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis (1996) 2.37
Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect (2002) 2.23
[Estimation of the sample size in clinical and epidemiological investigations]. Med Clin (Barc) (1998) 2.18
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect (2014) 2.13
Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in beta-lactam antibiotic resistance. J Bacteriol (1999) 2.12
Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania. J Clin Microbiol (1999) 2.11
High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. J Epidemiol Community Health (1998) 2.08
In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis. Int J Antimicrob Agents (2002) 2.07
Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. J Clin Microbiol (2001) 2.06
Management of giant anal condyloma by wide local excision and anoplasty. Colorectal Dis (2012) 1.99
[Cefixime versus amoxicillin plus netilmicin in the treatment of community-acquired non-complicated acute pyelonephritis]. Med Clin (Barc) (1998) 1.95
Nucleotide sequence of a 13.9 kb segment of the 90 kb virulence plasmid of Salmonella typhimurium: the presence of fimbrial biosynthetic genes. Mol Microbiol (1993) 1.89
Brucella endocarditis: clinical, diagnostic, and therapeutic approach. Eur J Clin Microbiol Infect Dis (2003) 1.81
Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant (2011) 1.78
Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes. Antimicrob Agents Chemother (1999) 1.78
Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases. Ann Rheum Dis (1997) 1.75
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease. Am J Gastroenterol (2013) 1.74
Analysis of electroencephalograms in Alzheimer's disease patients with multiscale entropy. Physiol Meas (2006) 1.73
Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain. Antimicrob Agents Chemother (2005) 1.73
Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect (2008) 1.73
Modulation of adherence of coagulase-negative staphylococci to Teflon catheters in vitro. Eur J Clin Microbiol (1986) 1.73
Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg (2009) 1.72
Diarrhea in children under 5 years of age from Ifakara, Tanzania: a case-control study. J Clin Microbiol (2000) 1.72
Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J Antimicrob Chemother (2000) 1.72
Digestive anisakiasis: clinical manifestations and diagnosis according to localization. Rev Esp Enferm Dig (2002) 1.70
Radio imaging of the very-high-energy gamma-ray emission region in the central engine of a radio galaxy. Science (2009) 1.66
Very-high-energy gamma rays from a distant quasar: how transparent is the universe? Science (2008) 1.65
Prevalence of Shigella enterotoxins 1 and 2 among Shigella strains isolated from patients with traveler's diarrhea. J Clin Microbiol (1999) 1.63
Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J Clin Microbiol (2005) 1.60
Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia. Clin Infect Dis (2001) 1.59
Dietary patterns and associated lifestyles in preconception, pregnancy and postpartum. Eur J Clin Nutr (2006) 1.58
Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection. Clin Microbiol Infect (2005) 1.56
Uptake and activity of rifapentine in human peritoneal macrophages and polymorphonuclear leukocytes. Eur J Clin Microbiol (1987) 1.55
Extended-spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clin Microbiol Infect (2010) 1.55
Evaluation of antimicrobial susceptibility of bacteria containing the qnr gene and FOX-5 beta-lactamase by four automated systems. Clin Microbiol Infect (2005) 1.54
Murine typhus as a common cause of fever of intermediate duration: a 17-year study in the south of Spain. Arch Intern Med (1999) 1.54
Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA (2001) 1.53
Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates. Microbiol Immunol (1998) 1.53
Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study. Neurology (2004) 1.52
Cerebrospinal fluid tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and interleukin-8 as diagnostic markers of cerebrospinal fluid infection in neurosurgical patients. Crit Care Med (2000) 1.49
Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol (1994) 1.49
Etiology of solitary pulmonary nodules in patients with human immunodeficiency virus infection. Clin Infect Dis (1997) 1.48
Mortality and hospital stay related to coagulase-negative Staphylococci bacteremia in non-critical patients. J Infect (2012) 1.46
Dual phosphorylation and autophosphorylation in mitogen-activated protein (MAP) kinase activation. Biochem J (1993) 1.45
Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis (2002) 1.44
Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients. Gut (2009) 1.43
[Complications associated with percutaneous renal biopsy in Spain, 50 years later]. Nefrologia (2010) 1.43
Genotypic identification of an undescribed spotted fever group rickettsia in Ixodes ricinus from southwestern Spain. Am J Trop Med Hyg (1998) 1.43
Treatment with pegylated interferon alpha-2b and ribavirin in patients unresponsive to previous treatments with standard interferon as monotherapy or combined with ribavirin. Rev Esp Enferm Dig (2005) 1.43
Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob Agents Chemother (2011) 1.43
[Pharmacokinetic study of zidovudine in parenteral drug addicts with human immunodeficiency virus infection]. Med Clin (Barc) (1993) 1.41
High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin Microbiol Infect (2007) 1.40
Variable very-high-energy gamma-ray emission from the microquasar LS I +61 303. Science (2006) 1.40
Pharmacokinetics of zidovudine in end-stage renal disease: influence of haemodialysis. AIDS (1992) 1.40
Schinzel-Giedion syndrome: report of two sibs. Am J Med Genet (1995) 1.40
[Respiratory cryptosporidiosis as first manifestation of AIDS]. Enferm Infecc Microbiol Clin (1996) 1.39
Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates. J Antimicrob Chemother (1999) 1.39
Detection of plasmid-mediated quinolone resistance genes in clinical isolates of Enterobacter spp. in Spain. J Clin Microbiol (2009) 1.39
[Usefulness of the disk diffusion method for evaluating the sensitivity of Neisseria meningitidis to penicillin and cefotaxime]. Enferm Infecc Microbiol Clin (1997) 1.39
Non-invasive interventions for improving well-being and quality of life in patients with lung cancer. Cochrane Database Syst Rev (2004) 1.38
Etiology of traveller's diarrhea in Spanish travellers to developing countries. Eur J Epidemiol (1993) 1.38
Comparison of acquisition of resistant microorganisms and infections in critically-ill patients with and without malignancies. Minerva Anestesiol (2013) 1.38
[Incidence of enteropathogens in patients with human immunodeficiency virus infection]. Med Clin (Barc) (1994) 1.38
[The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia]. Med Clin (Barc) (1993) 1.38
[Thrombocytopenia associated with human immunodeficiency virus infection. Immunologic study of 60 patients addicted to parenteral drugs]. Med Clin (Barc) (1993) 1.38
Uptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cells. Antimicrob Agents Chemother (1992) 1.37
Postoperative spondylodiskitis: etiology, clinical findings, prognosis, and comparison with nonoperative pyogenic spondylodiskitis. Clin Infect Dis (1999) 1.37
Patients with obstructive sleep apnea exhibit genioglossus dysfunction that is normalized after treatment with continuous positive airway pressure. Am J Respir Crit Care Med (1999) 1.37
Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clin Microbiol Infect (2005) 1.36